glp 1 suppress appetite GLP-1 Glucagon-Like Peptide-1 Based Therapies: A

After 1:1 propensity score matching, there were 3,048 patients in each cohort

Glucagon-like peptide 1 (GLP-1) agonists are a class of drugs that are approved by the FDA for weight loss in obese people without diabetes or to treat type 2 diabetes

Pancreatitis, on the other hand, was identified as an absolute contraindication for the use of GLP-1, with no recommendation for initial testing or monitoring of pancreatic enzymes like lipase

Endocrinology 140 , 11321140 (1999)

Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study

This class of medications is ideal for patients who are looking to shed extra pounds effectively